Literature DB >> 15973316

Longitudinal changes in bone density in children and adolescents with moderate to severe cerebral palsy.

Richard C Henderson1, John A Kairalla, John W Barrington, Almas Abbas, Richard D Stevenson.   

Abstract

OBJECTIVE: To assess the natural history of "growth" in bone mineral density (BMD) in children and adolescents with moderate to severe cerebral palsy (CP). STUDY
DESIGN: A prospective, longitudinal, observational study of BMD in 69 subjects with moderate to severe spastic CP ages 2.0 to 17.7 years. Fifty-five subjects were observed for more than 2 years and 40 subjects for more than 3 years. Each evaluation also included assessments of growth, nutritional status, Tanner stage, general health, and various clinical features of CP.
RESULTS: Lower BMD z-scores at the initial evaluation were associated with greater severity of CP as judged by gross motor function and feeding difficulty, and with poorer growth and nutrition as judged by weight z-scores. BMD increased an average of 2% to 5%/y in the distal femur and lumbar spine, but ranged widely from +42%/y to -31%. In spite of increases in BMD, distal femur BMD z-scores decrease with age in this population.
CONCLUSIONS: Children with severe CP develop over the course of their lives clinically significant osteopenia. Unlike elderly adults, this is not primarily from true losses in bone mineral, but from a rate of growth in bone mineral that is diminished relative to healthy children. The efficacy of interventions to increase BMD can truly be assessed only with a clear understanding of the expected changes in BMD without intervention.

Entities:  

Mesh:

Year:  2005        PMID: 15973316     DOI: 10.1016/j.jpeds.2005.02.024

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  37 in total

Review 1.  Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies.

Authors:  Andres Moreno-De-Luca; David H Ledbetter; Christa L Martin
Journal:  Lancet Neurol       Date:  2012-01-18       Impact factor: 44.182

Review 2.  Opportunities for early intervention based on theory, basic neuroscience, and clinical science.

Authors:  Beverly D Ulrich
Journal:  Phys Ther       Date:  2010-10-21

Review 3.  Growth and nutrition disorders in children with cerebral palsy.

Authors:  Michelle N Kuperminc; Richard D Stevenson
Journal:  Dev Disabil Res Rev       Date:  2008

Review 4.  The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position.

Authors:  David R Weber; Alison Boyce; Catherine Gordon; Wolfgang Högler; Heidi H Kecskemethy; Madhusmita Misra; Diana Swolin-Eide; Peter Tebben; Leanne M Ward; Halley Wasserman; Christopher Shuhart; Babette S Zemel
Journal:  J Clin Densitom       Date:  2019-07-10       Impact factor: 2.617

Review 5.  Pain in cognitively impaired children: a focus for general pediatricians.

Authors:  M Massaro; S Pastore; A Ventura; E Barbi
Journal:  Eur J Pediatr       Date:  2012-03-20       Impact factor: 3.183

6.  Efficacy of home-based virtual cycling training on bone mineral density in ambulatory children with cerebral palsy.

Authors:  C-L Chen; C-Y Chen; M-Y Liaw; C-Y Chung; C-J Wang; W-H Hong
Journal:  Osteoporos Int       Date:  2012-09-28       Impact factor: 4.507

7.  Nutrition in neurologically impaired children.

Authors: 
Journal:  Paediatr Child Health       Date:  2009-07       Impact factor: 2.253

8.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2009-08-19       Impact factor: 2.253

9.  Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.

Authors:  C Marciniak; J Gabet; J Lee; M Ma; K Brander; N Wysocki
Journal:  Osteoporos Int       Date:  2015-11-17       Impact factor: 4.507

Review 10.  Fractures in children with cerebral palsy.

Authors:  M Zulf Mughal
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.